news-med.jpg

Aptuit Announces Strategic Provider Agreement with Regulus Therapeutics

Provides range of discovery, CMC and non-clinical services Greenwich, CT, June 8, 2017 - Dr. Jonathan Goldman, CEO, Aptuit LLC, announced a strategic provider relationship between Aptuit, a leading Partnership Research Organization, and Regulus Therapeutics Inc (Nasdaq:RGLS), an innovative ...

Topics: Drug design and discovery, Drug Development, Partner Research Organization, microRNA Read More